Inflammatory leiomyosarcoma (ILMS) is a very rare soft tissue tumor that usually follows an indolent clinical course, but long-term follow-up studies are lacking. Recent publications primarily focused on its genetic profile characterized by a near haploid genome. One study also showed these tumors to have upregulation of genes known to be crucial for skeletal muscle differentiation. Nevertheless, immunohistochemical expression of skeletal muscle markers, as well as markers that would help to distinguish ILMS from a long list of relevant differential diagnostic entities, has not been extensively studied. Nine cases of ILMS were collected and stained by a broad IHC panel which, besides others, contained MyoD1, myogenin, and PAX-7. A subset of cases was also analyzed by 2 different NGS assays and by MDM2 fluorescence in situ hybridization. Five male and 4 female patients ranged in age from 25 to 54 years (mean, 36 years). The tumors showed a predilection for intramuscular sites of the lower limbs (n = 4) and back (n = 2), whereas the remaining 3 cases affected an unspecified skeletal muscle, lung, and omentum. Follow-up with an average length of 10.6 years (range 0.5-22) was available for 8 patients. The omental tumor spread locally within the abdominal cavity, but the patient has been free of disease 7 years after treatment. None of the 5 patients with somatic soft tissue tumors (and follow-up longer than 1.5 years) had either recurrence or metastasis. Immunohistochemical studies revealed a substantial expression of skeletal muscle markers in almost all cases. This phenotype coupled with a highly characteristic genotype and significantly more indolent clinical behavior as compared with conventional leiomyosarcoma of deep soft tissue offers a strong rationale to change the current nomenclature. Based on the clinicopathological features and gene expression profile, we propose the name low-grade inflammatory myogenic tumor.

Biomedical Center Charles University Faculty of Medicine in Plzen Plzen Czech Republic

Bioptical Laboratory Ltd Plzen Czech Republic

CSD Health Care Ltd Kyiv Ukraine

Department of Pathology 1st Faculty of Medicine Charles University Prague Prague Czech Republic

Department of Pathology Charles University Faculty of Medicine in Plzen Plzen Czech Republic

Department of Pathology Cleveland Clinic Cleveland OH USA

Department of Pathology Kyoto Prefectural University of Medicine Kyoto Japan

Department of Radiology Charles University Faculty of Medicine in Plzen Plzen Czech Republic

Institute of Pathology University Hospital Friedrich Alexander University Erlangen Nürnberg Erlangen Germany

Zobrazit více v PubMed

Merchant W, Calonje E, Fletcher CD (1995) Inflammatory leiomyosarcoma: a morphological subgroup within the heterogeneous family of so-called inflammatory malignant fibrous histiocytoma. Histopathology 27:525–532 DOI

Dal Cin P, Sciot R, Fletcher CD, Samson I, De Vos R, Mandahl N et al (1998) Inflammatory leiomyosarcoma may be characterized by specific near-haploid chromosome changes. J Pathol 185:112–115 DOI

Nord KH, Paulsson K, Veerla S, Wejde J, Brosjo O, Mandahl N et al (2012) Retained heterodisomy is associated with high gene expression in hyperhaploid inflammatory leiomyosarcoma. Neoplasia 14:807–812 DOI

Chang A, Schuetze SM, Conrad EU 3rd, Swisshelm KL, Norwood TH, Rubin BP (2005) So-called “inflammatory leiomyosarcoma”: a series of 3 cases providing additional insights into a rare entity. Int J Surg Pathol 13:185–195 DOI

Arbajian E, Koster J, Vult von Steyern F, Mertens F (2018) Inflammatory leiomyosarcoma is a distinct tumor characterized by near-haploidization, few somatic mutations, and a primitive myogenic gene expression signature. Mod Pathol 31:93–100 DOI

Michal M, Agaimy A, Contreras AL, Svajdler M, Kazakov DV, Steiner P, Grossmann P, Martinek P, Hadravsky L, Michalova K, Svajdler P, Szep Z, Michal M, Fetsch JF (2018) Dysplastic lipoma: a distinctive atypical lipomatous neoplasm with anisocytosis, focal nuclear atypia, p53 overexpression, and a lack of MDM2 gene amplification by FISH; a report of 66 cases demonstrating occasional multifocality and a rare association with retinoblastoma. Am J Surg Pathol 42:1530–1540 DOI

Svajdler M, Michal M, Martinek P, Ptakova N, Kinkor Z, Szepe P et al (2019) Fibro-osseous pseudotumor of digits and myositis ossificans show consistent COL1A1-USP6 rearrangement: a clinicopathological and genetic study of 27 cases. Hum Pathol 88:39–47 DOI

Donati M, Kastnerova L, Martinek P, Grossmann P, Sticova E, Hadravsky L et al (2019) Spitz tumors with ROS1 fusions: A clinicopathological study of 6 cases, including FISH for chromosomal copy number alterations and mutation analysis using next-generation sequencing. Am J Dermatopathol. https://doi.org/10.1097/DAD.0000000000001499

Aspberg F, Mertens F, Bauer HC, Lindholm J, Mitelman F, Mandahl N (1995) Near-haploidy in two malignant fibrous histiocytomas. Cancer Genet Cytogenet 79:119–122 DOI

de Saint Aubain Somerhausen N, Gengler C, Reginster M, Christophe J, Ronsse G, Gebhart M (2003) Inflammatory leiomyosarcoma: a case report. Ann Pathol 23:336–339 PubMed

Morovic A, Delcore R, Damjanov I (2003) Inflammatory leiomyosarcoma of the retroperitoneum. Pathol Res Pract 199:41–43 discussion 5-6 DOI

Efstathopoulos N, Lazarettos J, Nikolaou V, Chronopoulos E (2006) Inflammatory leiomyosarcoma of the ankle: a case report and review of the literature. J Foot Ankle Surg 45:127–130 DOI

Morita I, Isoda R, Hirabayashi Y, Naomoto Y (2016) A long-living case of carotid aneurysm caused by inflammatory leiomyosarcoma. Asian Cardiovasc Thorac Ann 24:801–804 DOI

Martinez AP, Fritchie KJ, Weiss SW, Agaimy A, Haller F, Huang HY et al (2019) Histiocyte-rich rhabdomyoblastic tumor: rhabdomyosarcoma, rhabdomyoma, or rhabdomyoblastic tumor of uncertain malignant potential? A histologically distinctive rhabdomyoblastic tumor in search of a place in the classification of skeletal muscle neoplasms. Mod Pathol 32:446–457 DOI

Salzano RP Jr, Tomkiewicz Z, Africano WA (1991) Dedifferentiated liposarcoma with features of rhabdomyosarcoma. Conn Med 55:200–202 PubMed

Tallini G, Erlandson RA, Brennan MF, Woodruff JM (1993) Divergent myosarcomatous differentiation in retroperitoneal liposarcoma. Am J Surg Pathol 17:546–556 DOI

Henricks WH, Chu YC, Goldblum JR, Weiss SW (1997) Dedifferentiated liposarcoma: a clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation. Am J Surg Pathol 21:271–281 DOI

Binh MB, Guillou L, Hostein I, Chateau MC, Collin F, Aurias A et al (2007) Dedifferentiated liposarcomas with divergent myosarcomatous differentiation developed in the internal trunk: a study of 27 cases and comparison to conventional dedifferentiated liposarcomas and leiomyosarcomas. Am J Surg Pathol 31:1557–1566 DOI

Weiss SW (2002) Smooth muscle tumors of soft tissue. Adv Anat Pathol 9:351–359 DOI

Marino-Enriquez A, Wang WL, Roy A, Lopez-Terrada D, Lazar AJ, Fletcher CD et al (2011) Epithelioid inflammatory myofibroblastic sarcoma: an aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK. Am J Surg Pathol 35:135–144 DOI

Antonescu CR, Suurmeijer AJ, Zhang L, Sung YS, Jungbluth AA, Travis WD, al-Ahmadie H, Fletcher CD, Alaggio R (2015) Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement. Am J Surg Pathol 39:957–967 DOI

Agaimy A, Michal M, Hadravsky L, Michal M (2016) Follicular dendritic cell sarcoma: clinicopathologic study of 15 cases with emphasis on novel expression of MDM2, somatostatin receptor 2A, and PD-L1. Ann Diagn Pathol 23:21–28 DOI

Alaggio R, Zhang L, Sung YS, Huang SC, Chen CL, Bisogno G, Zin A, Agaram NP, LaQuaglia M, Wexler LH, Antonescu CR (2016) A molecular study of pediatric spindle and sclerosing rhabdomyosarcoma: identification of novel and recurrent VGLL2-related fusions in infantile cases. Am J Surg Pathol 40:224–235 PubMed PMC

Le Loarer F, Cleven AHG, Bouvier C, Castex MP, Romagosa C, Moreau A et al (2019) A subset of epithelioid and spindle cell rhabdomyosarcomas is associated with TFCP2 fusions and common ALK upregulation. Mod Pathol. https://doi.org/10.1038/s41379-019-0323-8

Sinonasal adenosquamous carcinomas arising in seromucinous hamartoma or respiratory epithelial adenomatoid hamartoma with atypical features: Report of five detailed clinicopathological and molecular characterisation of rare entity

Nasal and sinonasal tumors formed by atypical adenomatous lesions arising in respiratory epithelial adenomatoid hamartoma/seromucinous hamartoma

Branchioma: immunohistochemical and molecular genetic study of 23 cases highlighting frequent loss of retinoblastoma 1 immunoexpression

Branchioma with a nested/organoid morphology: molecular profiling of a distinctive potentially misleading variant and reappraisal of potential relationship to CD34-positive/Rb1-deficient tumors of the neck

Biphenotypic sinonasal sarcoma with PAX3::MAML3 fusion transforming into high-grade rhabdomyosarcoma: report of an emerging rare phenomenon